Versant Capital Management’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-104
Closed -$1K 1491
2017
Q2
$1K Hold
104
﹤0.01% 1333
2017
Q1
$1K Sell
104
-49
-32% -$746 ﹤0.01% 1332
2016
Q4
$2K Sell
153
-895
-85% -$13.6K ﹤0.01% 1191
2016
Q3
$16K Buy
1,048
+102
+11% +$1.68K 0.01% 642
2016
Q2
$15K Buy
946
+687
+265% +$12.1K 0.01% 632
2016
Q1
$6K Buy
259
+154
+147% +$4.73K ﹤0.01% 908
2015
Q4
$3K Buy
+105
New +$3.93K ﹤0.01% 1050

Other funds holding HHS

Versant Capital Management's HHS Position: Q3 2017 in Review

Versant Capital Management sold out of Harte-Hanks (HHS) in Q3 2017, closing a stake of 104 shares — an estimated $1K sold.

Versant Capital Management first reported a position in HHS in Q4 2015 and held it in 7 quarters. The position peaked at $16K in Q3 2016. 55 funds tracked by Wall St. Rank hold HHS as of Q3 2017.

  • Versant Capital Management reported no remaining Harte-Hanks position as of Q3 2017 after selling out during the quarter.
  • Versant Capital Management sold 104 Harte-Hanks shares in Q3 2017, an estimated $1K.
  • Versant Capital Management first reported a position in Harte-Hanks in Q4 2015 and held it in 7 quarters.
  • Versant Capital Management's Harte-Hanks position peaked at $16K in Q3 2016.
  • 55 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2017.

Based on Versant Capital Management's 13F filing for Q3 2017, filed 23 Apr 2018.